BDBM393259 N-[(2-methyl-1,3- thiazol-5-yl)methyl]-5- (thiophene-2- sulfonamidomethyl) pyrazine-2-carboxamide::US9963434, Table 12.202

SMILES Cc1ncc(CNC(=O)c2cnc(CNS(=O)(=O)c3cccs3)cn2)s1

InChI Key InChIKey=SSXUHHISMHHIAV-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 393259   

TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Luc Therapeutics

US Patent
LigandPNGBDBM393259(US9963434, Table 12.202 | N-[(2-methyl-1,3- thiazo...)
Affinity DataIC50: 3.77E+3nMAssay Description:Cell Culture and plating: HEK293 cells expressing NR1/NR2A (Chantest, Cleveland, Ohio) were grown to 70-80% confluency as an adherent monolayer in st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2020
Entry Details
Go to US Patent